Advances in the management of multiple sclerosis spasticity: experiences from recent studies and everyday clinical practice

Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain

(2013) Antonio García-Merino   Expert Review of Neurotherapeutics

Multiple sclerosis spasticity daily management: retrospective data from Europe

(2013) Thomas Berger   Expert Review of Neurotherapeutics

A new multiple sclerosis spasticity treatment option: effect in everyday clinical practice and cost–effectiveness in Germany

(2013) Peter Flachenecker   Expert Review of Neurotherapeutics

Spasticity in multiple sclerosis: results of a patient survey

(2013) C. Oreja-Guevara et al.   INTERNATIONAL JOURNAL OF NEUROSCIENCE

A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis

(2011) A. Novotna et al.   EUROPEAN JOURNAL OF NEUROLOGY

Rehabilitation in practice: Spasticity management

(2010) VL Stevenson   CLINICAL REHABILITATION

A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis

(2010) C. Collin et al.   NEUROLOGICAL RESEARCH

Stop using the Ashworth Scale for the assessment of spasticity

(2009) J F M Fleuren et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY